HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 64 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,507,015 | +31.3% | 1,778,000 | +29.0% | 0.08% | +42.6% |
Q2 2023 | $1,147,626 | -96.7% | 1,378,000 | -96.7% | 0.05% | -96.9% |
Q1 2023 | $35,110,320 | -37.3% | 41,798,000 | -1.4% | 1.74% | -23.6% |
Q4 2022 | $56,016,826 | +950.2% | 42,407,000 | +576.8% | 2.28% | +721.7% |
Q3 2022 | $5,334,000 | – | 6,266,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 71,432 | $63,617,000 | 4.32% |
Western Asset Management Company, LLC | 15,600,000 | $13,690,000 | 4.04% |
CAMDEN ASSET MANAGEMENT L P /CA | 70,849,000 | $61,727,000 | 1.84% |
ZAZOVE ASSOCIATES LLC | 16,992,000 | $14,985,000 | 1.32% |
Penn Mutual Asset Management, LLC | 1,305,000 | $1,137,000 | 1.32% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 64,750,000 | $56,413,000 | 0.72% |
CQS (US), LLC | 10,000,000 | $8,777,000 | 0.61% |
ADVENT CAPITAL MANAGEMENT /DE/ | 28,859,000 | $25,319,000 | 0.40% |
Context Capital Management, LLC | 4,122 | $3,632,000 | 0.24% |
Hudson Bay Capital Management LP | 19,500,000 | $17,152,000 | 0.23% |